Max Chat
Boston Scientific
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
71.59 | 52.65 | 35.98% | 58.61 | +22.14% |
| P/S |
|
7.93 | 4.03 | 96.76% |
|
|
| P/BV |
|
6.03 | 10.86 | -44.47% |
|
|
| P/FCF |
|
27.78 | 39.64 | -29.9% |
|
|
| Ev/Ebitda |
|
36.41 | 16.29 | 123.5% |
|
|
| Ev/S |
|
8.57 | 4.35 | 97.07% |
|
|
| Ev/FCF |
|
54.24 | 52.22 | 3.87% |
|
|
| E/P |
|
0.0252 | 0.2095 | -87.97% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
23.53 | 18.92 | 24.34% | 23.27 | +1.12% |
| ROE |
|
9.03 | -83.32 | -110.84% |
|
|
| ROA |
|
4.98 | 6.38 | -22% |
|
|
| ROIC |
|
4.77 | 15.07 | -68.34% |
|
|
| ROS |
|
11.07 | 9.34 | 18.58% |
|
|
| ROCE |
|
12.14 | 84.77 | -85.68% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
5/10
|
2.83 | 1.04 | 172.51% | 3.04 | -6.86% |
| Nеt Debt/Ebitda |
|
2.72 | 1.42 | 92.05% |
|
|
| Debt/Ratio |
|
0.283 | 0.2741 | 3.24% |
|
|
| Debt/Equity |
|
0.7904 | 15.68 | -94.96% |
|
|
| Debt/Net Income |
|
6.01 | 6.8 | -11.57% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.28 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 6.75 | -100% | ||
| DSI |
|
0 | 0.7413 | -100% |
|
|
| Average dividend growth |
|
0 | -4.1 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.34 | -100% |
|
|
| Average percentage for payments |
|
11.35 | 44.08 | -74.25% |
|
|
| Difference from average difference in sector |
|
-1.28 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
8/10
|
68.99 | 54.39 | 26.84% | ||
| Growth impulse Ebitda in 5 years |
|
115.3 | -89.73 | -228.5% | ||
| Growth impulse Net Income in 5 years |
|
-1424.29 | -83.26 | 1610.65% | ||
| Growth impulse FCF in 5 years |
|
134.07 | -81.95 | -263.6% | ||
| Growth impulse EPS in 5 years |
|
-1362.88 | 39.71 | -3532.08% |
IP Score
3.78/10
